Special Article

You have full text access to this OnlineOpen article

Guidelines for immunologic laboratory testing in the rheumatic diseases: Anti-Sm and anti-RNP antibody tests

  1. Elizabeth Benito-Garcia1,*,
  2. Peter H. Schur1,
  3. Robert Lahita2,
  4. The American College of Rheumatology Ad Hoc Committee on Immunologic Testing Guidelines†

Article first published online: 8 DEC 2004

DOI: 10.1002/art.20836

Issue

Arthritis Care & Research

Arthritis Care & Research

Volume 51, Issue 6, pages 1030–1044, 15 December 2004

Additional Information

How to Cite

Benito-Garcia, E., Schur, P. H., Lahita, R. and The American College of Rheumatology Ad Hoc Committee on Immunologic Testing Guidelines (2004), Guidelines for immunologic laboratory testing in the rheumatic diseases: Anti-Sm and anti-RNP antibody tests. Arthritis & Rheumatism, 51: 1030–1044. doi: 10.1002/art.20836

Author Information

  1. 1

    Brigham and Women's Hospital, Boston, Massachusetts

  2. 2

    Jersey City Medical Center, Jersey City, New Jersey

  1. †

    American College of Rheumatology Ad Hoc Committee on Immunologic Testing Guidelines members: Arthur F. Kavanaugh, MD (Chair): University of California at San Diego; Daniel H. Solomon, MD, MPH, Peter H. Schur, MD: Brigham and Women's Hospital, Boston, Massachusetts; John D. Reveille, MD: University of Texas Health Science Center, Houston, Texas; Yvonne R. S. Sherrer, MD: Center for Rheumatology, Immunology & Arthritis, Fort Lauderdale, Florida; Robert Lahita, MD, PhD: Jersey City Medical Center, Jersey City, New Jersey.

*Division of Rheumatology, Immunology, and Allergy, Brigham & Women's Hospital, Section of Clinical Sciences, 221 Longwood Avenue, BLI 341 A-G, Boston, MA 02115

  1. †

    American College of Rheumatology Ad Hoc Committee on Immunologic Testing Guidelines members: Arthur F. Kavanaugh, MD (Chair): University of California at San Diego; Daniel H. Solomon, MD, MPH, Peter H. Schur, MD: Brigham and Women's Hospital, Boston, Massachusetts; John D. Reveille, MD: University of Texas Health Science Center, Houston, Texas; Yvonne R. S. Sherrer, MD: Center for Rheumatology, Immunology & Arthritis, Fort Lauderdale, Florida; Robert Lahita, MD, PhD: Jersey City Medical Center, Jersey City, New Jersey.

Publication History

  1. Issue published online: 8 DEC 2004
  2. Article first published online: 8 DEC 2004
  3. Manuscript Accepted: 29 APR 2004
  4. Manuscript Received: 13 FEB 2004

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (153K)

REFERENCES

  • 1
    Guidelines for immunologic laboratory testing in the rheumatic diseases: an introduction. Arthritis Rheum 2002; 47: 429–33.
    Direct Link:
  • 2
    Kavanaugh AF, Solomon DH. Guidelines for immunologic laboratory testing in the rheumatic diseases: anti-DNA antibody tests. Arthritis Rheum 2002; 47: 546–55.
    Direct Link:
  • 3
    Kavanaugh A, Tomar R, Reveille J, Solomon DH, Homburger HA, American College of Pathologists. Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. Arch Pathol Lab Med 2000; 124: 71–81.
  • 4
    Reveille JD, Solomon DH. Evidence-based guidelines for the use of immunologic tests: anticentromere, Scl-70, and nucleolar antibodies. Arthritis Rheum 2003; 49: 399–412.
    Direct Link:
  • 5
    Solomon DH, Kavanaugh AJ, Schur PH. Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Rheum 2002; 47: 434–44.
    Direct Link:
  • 6
    Tan EM, Kunkel HG. Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus. J Immunol 1966; 96: 464–71.
  • 7
    Busch H, Reddy R, Rothblum L, Choi YC. SnRNAs, SnRNPs, and RNA processing. Annu Rev Biochem 1982; 51: 617–54.
  • 8
    Lerner MR, Steitz JA. Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus. Proc Natl Acad Sci U S A 1979; 76: 5495–9.
  • 9
    Mattioli M, Reichlin M. Characterization of a soluble nuclear ribonucleoprotein antigen reactive with SLE sera. J Immunol 1971; 107: 1281–90.
  • 10
    Reichlin M, Mattioli M. Correlation of a precipitin reaction to an RNA protein antigen and a low prevalence of nephritis in patients with systemic lupus erythematosus. N Engl J Med 1972; 286: 908–11.
  • 11
    Sharp GC, Irvin WS, LaRoque RL, Velez C, Daly V, Kaiser AD, et al. Association of autoantibodies to different nuclear antigens with clinical patterns of rheumatic disease and responsiveness to therapy. J Clin Invest 1971; 50: 350–9.
  • 12
    Northway JD, Tan EM. Differentiation of antinuclear antibodies giving speckled staining patterns in immunofluorescence. Clin Immunol Immunopathol 1972; 1: 140–54.
  • 13
    Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease—an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 1972; 52: 148–59.
  • 14
    Mattioli M, Reichlin M. Physical association of two nuclear antigens and mutual occurrence of their antibodies: the relationship of the SM and RNAprotein (MO) systems in SLE sera. J Immunol 1973; 110: 1318–24.
  • 15
    Lerner MR, Boyle JA, Mount SM, Wolin SL, Steitz JA. Are snRNPs involved in splicing? Nature 1980; 283: 220–4.
  • 16
    Steitz JA. “Snurps”. Sci Am 1988; 258: 56–60, 63.
  • 17
    Steitz JA, Black DL, Gerke V, Parker KA, Kramer A, Fendeway D, et al. Structure and function of major and minor small nuclear ribonucleoprotein particles. Berlin: Springer-Verlag; 1988. p. 115–54.
  • 18
    Tan EM. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 1989; 44: 93–151.
  • 19
    Pan LT, Tin SK, Boey ML, Fong KY. The sensitivity and specificity of autoantibodies to the Sm antigen in the diagnosis of systemic lupus erythematosus. Ann Acad Med Singapore 1998; 27: 21–3.
  • 20
    Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271–7.
    Direct Link:
  • 21
    Craft J. Antibodies to snRNPs in systemic lupus erythematosus. Rheum Dis Clin North Am 1992; 18: 311–35.
  • 22
    Maddison PJ, Mogavero H, Reichlin M. Patterns of clinical disease associated with antibodies to nuclear ribonucleoprotein. J Rheumatol 1978; 5: 407–11.
  • 23
    Sanchez-Guerrero J, Lew RA, Fossel AH, Schur PH. Utility of anti-Sm, anti-RNP, anti-Ro/SS-A, and anti-La/SS-B (extractable nuclear antigens) detected by enzyme-linked immunosorbent assay for the diagnosis of systemic lupus erythematosus. Arthritis Rheum 1996; 39: 1055–61.
    Direct Link:
  • 24
    Williams DG, Stocks MR, Charles PJ, Maini RN. Antibodies to La, Jo-1, nRNP and Sm detected by multi-track immunoblotting using a novel filter holder: a comparative study with counterimmunoelectrophoresis and immunodiffusion using sera from patients with systemic lupus erythematosus and Sjogren's syndrome. J Immunol Methods 1986; 91: 65–73.
  • 25
    Barada FA Jr, Andrews BS, Davis JS, Taylor RP. Antibodies to Sm in patients with systemic lupus erythematosus: correlation of Sm antibody titers with disease activity and other laboratory parameters. Arthritis Rheum 1981; 24: 1236–44.
    Direct Link:
  • 26
    Fisher DE, Reeves WH, Wisniewolski R, Lahita RG, Chiorazzi N. Temporal shifts from Sm to ribonucleoprotein reactivity in systemic lupus erythematosus. Arthritis Rheum 1985; 28: 1348–55.
    Direct Link:
  • 27
    Winn DM, Wolfe JF, Lindberg DA, Fristoe FH, Kingsland L, Sharp GC. Identification of a clinical subset of systemic lupus erythematosus by antibodies to the Sm antigen. Arthritis Rheum 1979; 22: 1334–7.
    Direct Link:
  • 28
    Homma M, Mimori T, Takeda Y, Akama H, Yoshida T, Ogasawara T, et al. Autoantibodies to the Sm antigen: immunological approach to clinical aspects of systemic lupus erythematosus. J Rheumatol 1987; 14 (Suppl 13): 188–93.
  • 29
    Boey ML, Peebles CL, Tsay G, Feng PH, Tan EM. Clinical and autoantibody correlations in Orientals with systemic lupus erythematosus. Ann Rheum Dis 1988; 47: 918–23.
  • 30
    Janwityanuchit S, Verasertniyom O, Vanichapuntu M, Vatanasuk M. Anti-Sm: its predictive value in systemic lupus erythematosus. Clin Rheumatol 1993; 12: 350–3.
  • 31
    Jaeschke R, Guyatt G, Sackett DL, Evidence-Based Medicine Working Group. Users' guides to the medical literature. III. How to use an article about a diagnostic test. A: are the results of the study valid? JAMA 1994; 271: 389–91.
  • 32
    Jaeschke R, Guyatt GH, Sackett DL, The Evidence-Based Medicine Working Group. Users' guides to the medical literature. III. How to use an article about a diagnostic test. B: what are the results and will they help me in caring for my patients? JAMA 1994; 271: 703–7.
  • 33
    Bonis PAL. Glossary of common biostatistical and epidemiological terms. In: RoseBD, editor. UptoDate. Wellesley (MA): UptoDate; 2004.
  • 34
    Shapiro DE. Issues in combining independent estimates of the sensitivity and specificity of a diagnostic test. Acad Radiol 1995; 2 Suppl 1: S37–47, S65–9, S83.
  • 35
    Lau J. Meta-test version 0.9. Boston: New England Medical Center; 2003.
  • 36
    Cox D. The analysis of binary data. London: Methuen; 1970.
  • 37
    Laird NM, Mosteller F. Some statistical methods for combining experimental results. Int J Technol Assess Health Care 1990; 6: 5–30.
  • 38
    Abuaf N, Johanet C, Chretien P, Absalon BI, Homberg JC, Buri JF. Detection of autoantibodies to Sm antigen in systemic lupus erythematosus by immunodiffusion, ELISA and immunoblotting: variability of incidence related to assays and ethnic origin of patients. Eur J Clin Invest 1990; 20: 354–9.
    Direct Link:
  • 39
    Bernstein RM, Bunn CC, Hughes GR, Francoeur AM, Mathews MB. Cellular protein and RNA antigens in autoimmune disease. Mol Biol Med 1984; 2: 105–20.
  • 40
    Gioud-Paquet M, Chamot AM, Bourgeois P, Meyer O, Kahn MF. [Symptomatic and prognostic differences according to ethnic group in systemic lupus erythematosus: a controlled study of 3 populations]. Presse Med 1988; 17: 103–6.
  • 41
    Maini RN, Charles PJ, Venables PJ. Antinuclear antibodies in the immunotaxonomy of connective tissue diseases. Scand J Rheumatol Suppl 1985; 56: 49–57.
  • 42
    Munves EF, Schur PH. Antibodies to Sm and RNP: prognosticators of disease involvement. Arthritis Rheum 1983; 26: 848–53.
    Direct Link:
  • 43
    Singh RR, Malaviya AN, Kailash S, Varghese T, Singh H, Sundaram KR. Antibodies to extractable nuclear antigens in connective tissue disorders in India: prevalence and clinical correlations. Asian Pac J Allergy Immunol 1989; 7: 107–12.
  • 44
    Froelich CJ, Wallman J, Skosey JL, Teodorescu M. Clinical value of an integrated ELISA system for the detection of 6 autoantibodies (ssDNA, dsDNA, Sm, RNP/Sm, SSA, and SSB). J Rheumatol 1990; 17: 192–200.
  • 45
    Field M, Williams DG, Charles P, Maini RN. Specificity of anti-Sm antibodies by ELISA for systemic lupus erythematosus: increased sensitivity of detection using purified peptide antigens. Ann Rheum Dis 1988; 47: 820–5.
  • 46
    McCain GA, Bell DA, Chodirker WB, Komar RR. Antibody to extractable nuclear antigen in the rheumatic diseases. J Rheumatol 1978; 5: 399–406.
  • 47
    Hamburger M, Hodes S, Barland P. The incidence and clinical significance of antibodies to extractable nuclear antigens. Am J Med Sci 1977; 273: 21–8.
  • 48
    Westgeest AA, van den Brink HG, de Jong J, Swaak AJ, Smeenk RJ. Antinuclear antibodies in patients with systemic lupus erythematosus: a comparison of counterimmunoelectrophoresis and immunoblotting. Rheumatol Int 1987; 7: 77–82.
  • 49
    Beaufils M, Kouki F, Mignon F, Camus JP, Morel-Maroger L, Richet G. Clinical significance of anti-Sm antibodies in systemic lupus erythematosus. Am J Med 1983; 74: 201–5.
  • 50
    Lopez-Longo FJ, Monteagudo I, Gonzalez CM, Moreno AC, Rodriguez Mahou M, Grau R, et al. Anti-BB'-Sm antibodies, anticardiolipin antibodies, and thrombosis in systemic lupus erythematosus. J Rheumatol 1998; 25: 1743–9.
  • 51
    Yamamoto AM, Amoura Z, Johannet C, Jeronimo AL, Campos H, Koutouzov S, et al. Quantitative radioligand assays using de novo-synthesized recombinant autoantigens in connective tissue diseases: new tools to approach the pathogenic significance of anti-RNP antibodies in rheumatic diseases. Arthritis Rheum 2000; 43: 689–98.
    Direct Link:
  • 52
    Yee CS, Hussein H, Skan J, Bowman S, Situnayake D, Gordon C. Association of damage with autoantibody profile, age, race, sex and disease duration in systemic lupus erythematosus. Rheumatology (Oxford) 2003; 42: 276–9.
  • 53
    Yamane K, Shome GP, Akama T, Suzuki H, Matsui Y, Kashiwagi H. Clinical features of patients with mild systemic lupus erythematosus. Scand J Rheumatol 1991; 20: 397–405.
  • 54
    Singh RR, Malaviya AN, Kailash S, Varghese T. Clinical significance of anti-Sm antibody in systemic lupus erythematosus & related disorders. Indian J Med Res 1991; 94: 206–10.
  • 55
    Ihn H, Yamane K, Yazawa N, Kubo M, Fujimoto M, Sato S, et al. Distribution and antigen specificity of anti-U1RNP antibodies in patients with systemic sclerosis. Clin Exp Immunol 1999; 117: 383–7.
    Direct Link:
  • 56
    Lundberg I, Nyman U, Pettersson I, Hedfors E. Clinical manifestations and anti-(U1)snRNP antibodies: a prospective study of 29 anti-RNP antibody positive patients. Br J Rheumatol 1992; 31: 811–7.
  • 57
    Nishikai M, Okano Y, Mukohda Y, Sato A, Ito M. Serial estimation of anti-RNP antibody titers in systemic lupus erythematosus, mixed connective tissue disease and rheumatoid arthritis. J Clin Lab Immunol 1984; 13: 15–9.
  • 58
    Yasuma M, Takasaki Y, Matsumoto K, Kodama A, Hashimoto H, Hirose S. Clinical significance of IgG anti-Sm antibodies in patients with systemic lupus erythematosus. J Rheumatol 1990; 17: 469–75.
  • 59
    Gripenberg M, Teppo AM, Friman C. Antibodies to Sm and SS-A demonstrated by enzyme immunoassay: correlation to clinical manifestations and disease activity in patients with systemic lupus erythematosus. Rheumatol Int 1991; 11: 209–13.
  • 60
    Ward MM, Studenski S. Clinical manifestations of systemic lupus erythematosus: identification of racial and socioeconomic influences. Arch Intern Med 1990; 150: 849–53.
  • 61
    Arnett FC, Hamilton RG, Roebber MG, Harley JB, Reichlin M. Increased frequencies of Sm and nRNP autoantibodies in American blacks compared to whites with systemic lupus erythematosus. J Rheumatol 1988; 15: 1773–6.
  • 62
    Gedalia A, Molina JF, Molina J, Uribe O, Malagon C, Espinoza LR. Childhood-onset systemic lupus erythematosus: a comparative study of African Americans and Latin Americans. J Natl Med Assoc 1999; 91: 497–501.
  • 63
    Cooper GS, Parks CG, Treadwell EL, St Clair EW, Gilkeson GS, Cohen PL, et al. Differences by race, sex and age in the clinical and immunologic features of recently diagnosed systemic lupus erythematosus patients in the southeastern United States. Lupus 2002; 11: 161–7.
  • 64
    Molina JF, Molina J, Garcia C, Gharavi AE, Wilson WA, Espinoza LR. Ethnic differences in the clinical expression of systemic lupus erythematosus: a comparative study between African-Americans and Latin Americans. Lupus 1997; 6: 63–7.
  • 65
    Isenberg DA, Garton M, Reichlin MW, Reichlin M. Long-term follow-up of autoantibody profiles in black female lupus patients and clinical comparison with Caucasian and Asian patients. Br J Rheumatol 1997; 36: 229–33.
  • 66
    Delpech A, Gilbert D, Daliphard S, Le Loet X, Godin M, Tron F. Antibodies to Sm, RNP and SSB detected by solid-phase ELISAs using recombinant antigens: a comparison study with counter immunoelectrophoresis and immunoblotting. J Clin Lab Anal 1993; 7: 197–202.
    Direct Link:
  • 67
    Maddison PJ, Skinner RP, Vlachoyiannopoulos P, Brennand DM, Hough D. Antibodies to nRNP, Sm, Ro(SSA) and La(SSB) detected by ELISA: their specificity and inter-relations in connective tissue disease sera. Clin Exp Immunol 1985; 62: 337–45.
  • 68
    Jaekel HP, Klopsch T, Benkenstein B, Grobe N, Baldauf A, Schoessler W, et al. Reactivities to the Sm autoantigenic complex and the synthetic SmD1-aa83–119 peptide in systemic lupus erythematosus and other autoimmune diseases. J Autoimmun 2001; 17: 347–54.
  • 69
    Nakamura RM, Peebles CL, Tan EM. Microhemagglutination test for detection of antibodies to nuclear Sm and ribonucleoprotein antigens in systemic lupus erythematosus and related diseases. Am J Clin Pathol 1978; 70: 800–7.
  • 70
    Notman DD, Kurata N, Tan EM. Profiles of antinuclear antibodies in systemic rheumatic diseases. Ann Intern Med 1975; 83: 464–9.
  • 71
    Kumar V, Beutner EH, Dabski K, Steger R, Koelle M. A standardized method of detecting antibodies to extractable nuclear antigens (RNP and Sm) by gel precipitation. J Clin Lab Immunol 1984; 15: 163–6.
  • 72
    Chan EY, Mok TM, Lawton JW, Ko OK, Ho L, Lau CS. Comparison of counter immunoelectrophoresis with immunoblotting for detection of anti-extractable nuclear antigen antibodies in systemic lupus erythematosus. Asian Pac J Allergy Immunol 1999; 17: 275–9.
  • 73
    Sulcebe G, Morcka K. Diagnostic and prognostic significance of different antinuclear antibodies in more than 1000 consecutive Albanian patients with rheumatic diseases. Clin Exp Rheumatol 1992; 10: 255–61.
  • 74
    Molden DP, Suzuki H, Nakamura RM. Assays for Sm and RNP antibodies: pitfalls and technical considerations. Diagn Immunol 1985; 3: 24–8.
  • 75
    Alba P, Bento L, Cuadrado MJ, Karim Y, Tungekar MF, Abbs I, et al. Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis. Ann Rheum Dis 2003; 62: 556–60.
  • 76
    Kurata N, Hara I, Kinashi M, Akita H, Ofuji T. The correlation of antibodies to nuclear ribonucleoprotein (RNP) and nuclear acidic protein (Sm) with nephritis in patients with systemic lupus erythematosus (SLE). Contrib Nephrol 1978; 9: 17–24.
  • 77
    Bastian HM, Roseman JM, McGwin G Jr, Alarcon GS, Friedman AW, Fessler BJ, et al. Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis. Lupus 2002; 11: 152–60.
View Full Article (HTML) Get PDF (153K)